SFCM
DYN icon

Seven Fleet Capital Management’s Dyne Therapeutics DYN Stock Holding History

Seven Fleet Capital Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-70,180
Closed -$1.37M – 121
2025
Q4 		$1.37M Buy
+70,180
New +$1.33M 0.93% 19

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Seven Fleet Capital Management's DYN Position: Q1 2026 in Review

Seven Fleet Capital Management sold out of Dyne Therapeutics (DYN) in Q1 2026, closing a stake of 70,180 shares — an estimated $1.37M sold.

Seven Fleet Capital Management first reported a position in DYN in Q4 2025 and held it in 1 quarter. The position peaked at $1.37M in Q4 2025. 228 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Seven Fleet Capital Management reported no remaining Dyne Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Seven Fleet Capital Management sold 70,180 Dyne Therapeutics shares in Q1 2026, an estimated $1.37M.
  • Seven Fleet Capital Management first reported a position in Dyne Therapeutics in Q4 2025 and held it in 1 quarter.
  • Seven Fleet Capital Management's Dyne Therapeutics position peaked at $1.37M in Q4 2025.
  • 228 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.